Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Candid Therapeutics, Inc.

Candid Therapeutics, Inc.

Stage unknownSan Diego, CAOther Health Care
Facts
Year of incorporation
2024sec.gov
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
1
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
0
Financing history
1 rounds
  1. Aug 19, 2024
    Form D equity offering · $206M (form d sold) · 33 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Candid Therapeutics, Inc. filed Form D: $206,203,454 sold of $206,203,454, Other Health Care”
Investors on record
0 edges
No named investor yet.
People
4 officers, 3 directors
Timeline
1
  1. Sep 13, 2024
    Candid Therapeutics, Inc. filed Form D: $206,203,454 sold of $206,203,454, Other Health Care
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
15 observations
Every observation on this company